Myelodysplastic Syndrome (MDS)

1 protocols meet the specified criteria

OCR40609

ACCESS: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies